(LCI) MC $18 m - Ph 3 data next week ...this low floater could double easily on positive outcome .. Pivotal Biosimilar Insulin Glargine Clinical Trial Top-line Results Anticipated in Current Quarter; BLA Filing Targeted for Middle of Calendar 2023